SCHEDULE 13D/A

Atea Pharmaceuticals Inc

Common Stock, $0.001 par value per share · CUSIP: 04683R106

Event date: 2025-03-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Radoff Family FoundationReported CIK 0001496916

  Shares: 175,000.00 · Class: 0.2%

• Radoff Bradley LouisReported CIK 0001380585

  Shares: 3,105,100.00 · Class: 3.6%

• JEC II Associates, LLCReported CIK 0001477326

  Shares: 1,300,000.00 · Class: 1.5%

• The MOS Trust

  Shares: 100,000.00 · Class: 0.1%

• MOS PTC, LLC

  Shares: 100,000.00 · Class: 0.1%

• Torok MichaelReported CIK 0001967237

  Shares: 1,500,000.00 · Class: 1.8%

• Berman Howard H.Reported CIK 0001952986

  Shares: 0.00 · Class: 0%

• Nerium Partners LPReported CIK 0001842372

  Shares: 54,000.00 · Class: 0.1%

• Nerium Capital LLC

  Shares: 54,000.00 · Class: 0.1%

• Flynn James P.Reported CIK 0001955965

  Shares: 54,000.00 · Class: 0.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.